EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bayesian Effect Size Ranking to Prioritise Genetic Risk Variants in Common Diseases for Follow‐Up Studies

Daniel J M Crouch, Jamie R J Inshaw, Catherine C Robertson, Esther Ng, Jia-Yuan Zhang, Wei-Min Chen, Suna Onengut-Gumuscu, Antony J Cutler, Carlo Sidore, Francesco Cucca, Flemming Pociot, Patrick Concannon und 2 weitere

Genetic Epidemiology · 2025-02 · 49 (1)

DOI: 10.1002/gepi.22608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Epidemiology, online erschienen am 03.01.2025. Verfasst von Daniel J M Crouch und 13 weiteren Autor:innen. Beteiligte Einrichtung: JDRF/Wellcome Diabetes and Inflammation Laboratory, Nuffield Department of Medicine, Centre for Human Genetics, NIHR Oxford Biomedical Research Centr…. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Diabetes Mellitus, Type 1, Bayes Theorem, Genetic Predisposition to Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NLM NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biological datasets often consist of thousands or millions of variables, e.g. genetic variants or biomarkers, and when sample sizes are large it is common to find many associated with an outcome of interest, for example, disease risk in a GWAS, at high levels of statistical significance, but with very small effects. The False Discovery Rate (FDR) is used to identify effects of interest based on ranking variables according to their statistical significance. Here, we develop a complementary measure to the FDR, the priorityFDR, that ranks variables by a combination of effect size and significance, allowing further prioritisation among a set of variables that pass a significance or FDR threshold. Applying to the largest GWAS of type 1 diabetes to date (15,573 cases and 158,408 controls), we identified 26 independent genetic associations, including two newly‐reported loci, with qualitatively lower priorityFDRs than the remaining 175 signals. We detected putatively causal type 1 diabetes risk genes using Mendelian Randomisation, and found that these were located disproportionately close to low priorityFDR signals ( p = 0.005), as were genes in the IL‐2 pathway ( p = 0.003). Selecting variables on both effect size and significance can lead to improved prioritisation for mechanistic follow‐up studies from genetic and other large biological datasets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genome-Wide Association StudyDiabetes Mellitus, Type 1Bayes TheoremGenetic Predisposition to DiseaseMendelian Randomization AnalysisPolymorphism, Single NucleotideHumansFollow-Up StudiesGenetic Variation

Stichwörter der Autor:innen

GWASeffect sizeempirical Bayesfalse discovery ratesignificance

Autor:innen und Institutionen

  • JDRF/Wellcome Diabetes and Inflammation Laboratory, Nuffield Department of Medicine, Centre for Human Genetics, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
  • Nuffield Department of Orthopaedics, Kennedy Institute of Rheumatology, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
  • Institute for Research in Genetics and Biomedicine (IRGB), Sardinia, Italy.
  • Department of Pediatrics, Herlev University Hospital, Copenhagen, Denmark.

Förderung

  • NIDDK NIH HHS
  • NLM NIH HHS
  • Wellcome Trust
  • This work was funded by JDRF grants 9-2011-253, 5-SRA-2015-130-A-N and 4-SRA-2017-473-A-N, and Wellcome grants 091157/Z/10/Z and 107212/Z/15/Z, to the Diabetes…
  • Fondazione di Sardegna

Zitieren

APA

Crouch, D. J. M., Inshaw, J. R. J., Robertson, C. C., Ng, E., Zhang, J. Y., Chen, W. M., Onengut-Gumuscu, S., Cutler, A. J., Sidore, C., Cucca, F., Pociot, F., Concannon, P., Rich, S. S., & Todd, J. A. (2025). Bayesian Effect Size Ranking to Prioritise Genetic Risk Variants in Common Diseases for Follow‐Up Studies. Genetic Epidemiology, 49(1). https://doi.org/10.1002/gepi.22608

Vancouver

Crouch DJM, Inshaw JRJ, Robertson CC, Ng E, Zhang JY, Chen WM, et al. Bayesian Effect Size Ranking to Prioritise Genetic Risk Variants in Common Diseases for Follow‐Up Studies. Genetic Epidemiology. 2025;49(1). doi:10.1002/gepi.22608

BibTeX
@article{Crouch2025,
  author = {Crouch, Daniel J M and Inshaw, Jamie R J and Robertson, Catherine C and Ng, Esther and Zhang, Jia-Yuan and Chen, Wei-Min and Onengut-Gumuscu, Suna and Cutler, Antony J and Sidore, Carlo and Cucca, Francesco and Pociot, Flemming and Concannon, Patrick and Rich, Stephen S and Todd, John A},
  title = {Bayesian Effect Size Ranking to Prioritise Genetic Risk Variants in Common Diseases for Follow‐Up Studies},
  journal = {Genetic Epidemiology},
  year = {2025},
  volume = {49},
  number = {1},
  doi = {10.1002/gepi.22608}
}
Kostenlos starten →